Faecal leucine levels differentiate paediatric inflammatory bowel disease from irritable bowel syndrome and functional abdominal pain
Journal of Pediatric Gastroenterology and Nutrition · 17.11.2026
DOI: 10.1002/jpn3.70669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 17.11.2026. Verfasst von Lana J Verstoep und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam University Medical Centre, Amsterdam, The Netherlands. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MDL fonds.
Abstract (Originalsprache)
Diagnosing inflammatory bowel disease (IBD) is based on a combination of clinical symptoms, with laboratory tests and endoscopy, to distinguish IBD from other conditions. Faecal amino acids, particularly leucine, have shown promising results as noninvasive biomarker for this purpose. This cross‐sectional study evaluated faecal leucine and the leucine/isoleucine ratio and its potential discriminative value between treatment‐naïve IBD patients and patients with irritable bowel syndrome (IBS) and functional abdominal pain‐ not otherwise specified (FAP‐NOS) patients, using a targeted liquid chromatography‐mass spectrometry (LC‐MS/MS) technique. Absolute leucine concentration and the leucine/isoleucine ratio were significantly higher in IBD, with the leucine/isoleucine ratio showing an area under the curve of 0.75 (95%CI: 0.65–0.84) with a cut‐off value of 1.44. Concluding, the leucine/isoleucine ratio can differentiate IBD from IBS and FAP‐NOS, and provides insights into disease pathogenesis. These findings highlight its potential as a novel noninvasive biomarker, although further studies are warranted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
- Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
- Amsterdam Reproduction & Development (AR&D) Research Institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
- Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
- Department of Laboratory Medicine, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
- Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
ORCID-Profile: Lana J Verstoep, Joëlle Vrijburg, Eva Vermeer, Marc A Benninga, Johan E van Limbergen, Robert de Jonge, Maja Bulatović Ćalasan, Eduard A Struys, Nanne K de Boer, Tim G J de Meij
Förderung
- MDL fonds
Zitieren
APA
Verstoep, L. J., Vrijburg, J., Vermeer, E., Benninga, M. A., van Limbergen, J. E., de Jonge, R., Bulatović Ćalasan, M., Struys, E. A., de Boer, N. K., & de Meij, T. G. J. (2026). Faecal leucine levels differentiate paediatric inflammatory bowel disease from irritable bowel syndrome and functional abdominal pain. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70669
Vancouver
Verstoep LJ, Vrijburg J, Vermeer E, Benninga MA, van Limbergen JE, de Jonge R, et al. Faecal leucine levels differentiate paediatric inflammatory bowel disease from irritable bowel syndrome and functional abdominal pain. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70669
BibTeX
@article{Verstoep2026,
author = {Verstoep, Lana J and Vrijburg, Joëlle and Vermeer, Eva and Benninga, Marc A and van Limbergen, Johan E and de Jonge, Robert and Bulatović Ćalasan, Maja and Struys, Eduard A and de Boer, Nanne K and de Meij, Tim G J},
title = {Faecal leucine levels differentiate paediatric inflammatory bowel disease from irritable bowel syndrome and functional abdominal pain},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70669}
}
EUVIMED